Cargando…

Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic

Detalles Bibliográficos
Autores principales: Meca-Lallana, Virginia, Aguirre, Clara, Cardeñoso, Laura, Alarcon, Teresa, Figuerola-Tejerina, Angels, del Río, Beatriz, Álvarez, Miguel Ruiz, Vivancos, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264931/
https://www.ncbi.nlm.nih.gov/pubmed/32544863
http://dx.doi.org/10.1016/j.msard.2020.102244
_version_ 1783541033507749888
author Meca-Lallana, Virginia
Aguirre, Clara
Cardeñoso, Laura
Alarcon, Teresa
Figuerola-Tejerina, Angels
del Río, Beatriz
Álvarez, Miguel Ruiz
Vivancos, José
author_facet Meca-Lallana, Virginia
Aguirre, Clara
Cardeñoso, Laura
Alarcon, Teresa
Figuerola-Tejerina, Angels
del Río, Beatriz
Álvarez, Miguel Ruiz
Vivancos, José
author_sort Meca-Lallana, Virginia
collection PubMed
description
format Online
Article
Text
id pubmed-7264931
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72649312020-06-02 Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic Meca-Lallana, Virginia Aguirre, Clara Cardeñoso, Laura Alarcon, Teresa Figuerola-Tejerina, Angels del Río, Beatriz Álvarez, Miguel Ruiz Vivancos, José Mult Scler Relat Disord Correspondence Elsevier B.V. 2020-09 2020-06-02 /pmc/articles/PMC7264931/ /pubmed/32544863 http://dx.doi.org/10.1016/j.msard.2020.102244 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Meca-Lallana, Virginia
Aguirre, Clara
Cardeñoso, Laura
Alarcon, Teresa
Figuerola-Tejerina, Angels
del Río, Beatriz
Álvarez, Miguel Ruiz
Vivancos, José
Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
title Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
title_full Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
title_fullStr Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
title_full_unstemmed Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
title_short Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
title_sort establishment of a safety protocol for the administration of treatments in multiple sclerosis during the sars-cov-2 pandemic
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264931/
https://www.ncbi.nlm.nih.gov/pubmed/32544863
http://dx.doi.org/10.1016/j.msard.2020.102244
work_keys_str_mv AT mecalallanavirginia establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic
AT aguirreclara establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic
AT cardenosolaura establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic
AT alarconteresa establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic
AT figuerolatejerinaangels establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic
AT delriobeatriz establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic
AT alvarezmiguelruiz establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic
AT vivancosjose establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic